A Phase I open label dose escalation safety and tolerability study of INCB054828 in subjects with advanced malignancies
Clinical Trial Grant
Awarded By
Incyte Corporation
Start Date
September 1, 2015
End Date
February 28, 2025
Awarded By
Incyte Corporation
Start Date
September 1, 2015
End Date
February 28, 2025